None listed
Conditions
Brief summary
The aim from this study is to test the hypothesis that alternate day oral iron as single dose is superior to daily single dose of oral iron in improving anemia and low side effects. This randomized open labelled controlled trial will be conducted at Student’s Clinic in Sultan Qaboos University (SQUH). It will focus on Omani female students aged between 17-25 years old with moderate iron deficiency anaemia .
Interventions
Eligible participants will be devided into two arms\groups .
Intervention arm : will receive ferrous sulphate iron supplements on alternatives days .
---------
This is an open-label RCT , no placebo will be used .
--------------
Drug : Ferrous sulphate
Dose : 200mg (containing 60 mg elemental iron)
Duration of administration : 12 weeks ( 3 months )
Mode of administration : oral tablets
Frequency : every second day
-------
Adherence will be monitored by via a questionnaire , it will be answere
Eligible participants will be devided into two arms\groups . Intervention arm : will receive ferrous sulphate iron supplements on alternatives days . --------- This is an open-label RCT , no placebo will be used . -------------- Drug : Ferrous sulphate Dose : 200mg (containing 60 mg elemental iron) Duration of administration : 12 weeks ( 3 months ) Mode of administration : oral tablets Frequency : every second day ------- Adherence will be monitored by via a questionnaire , it will be answered by the participatnts during each follow up visit .
Sponsors
Sultan Qaboos University
Study design
Allocation
Randomised controlled trial
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
17 Years to 25 Years
Healthy volunteers
No
Inclusion criteria
College students at Sultan Qaboos University in Oman. Age 17-25 years old. Female gender. Moderate anemia of hemoglobin of 8.0- 10.9 g/dL with microcytic hypochromic anemia. Low iron stores\Ferritin.
Exclusion criteria
Mild anaemia of haemoglobin levels between 11.0–11.9 g/dL as majority will not need iron supplements and usually treated with modification of diet to be iron rich diet. Chronic diseases (kidney disease, chronic liver disease, cardiac failure). Malignancy. Hemolytic anemias (including hemoglobinopathies) . Pregnancy \ Lactation . Patients who received blood transfusions within past 3 months and/or suffering from severe anemia requiring transfusion were also excluded. Severe iron deficiency anemia , HB: less than 7.9 g/dL
Outcome results
None listed